Dr. Caitlin Elizabeth Welch, MD

Dr. Welch practices at MaineHealth Mid Coast Hospital in Brunswick, Maine, part of MaineHealth.

Dr. Welch's NPI, 1003235664, was assigned on April 10, 2014. Dr. Welch graduated from State University of New York at Stony Brook, School of Medicine in 2014. Dr. Welch holds Maine license MD23575.

Dr. Welch's primary practice is MaineHealth Mid Coast Hospital, at 123 Medical Center Drive, Brunswick, ME 04011 in Cumberland County. The practice phone is (207) 729-0181.

Dr. Welch's primary practice is MaineHealth Mid Coast Hospital in Brunswick, Maine, part of MaineHealth. Dr. Welch is also affiliated with MaineHealth Maine Medical Center. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Welch to 3 more hospitals, 1 clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Welch practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Welch's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Welch is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Welch is licensed in Maine.

CMS data shows 971 Medicare services from Dr. Welch across 11 procedure codes in 2024, for 276 Medicare patients. Medicare paid $34,791 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 276 Medicare patients who saw Dr. Welch in 2024. The largest group is 75 to 84, with 112 patients. 71% of them have high blood pressure, and 68% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Welch's median patient age at 74, with 59% women.

In 2024, Dr. Welch wrote 2,547 Medicare Part D claims for 405 patients. 46% of them were for generic drugs. CMS names the drug for 2,448 of them, across 39 drugs with 11 or more claims each, at $1,097,989 in total drug cost. In 2023, CMS named 2,026 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Welch for performance year 2024, reported through an alternative payment model (APM). Dr. Welch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Welch as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Welch from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $38.

Dr. Welch graduated from State University of New York at Stony Brook, School of Medicine in 2014.